Great West Life Assurance CO Biotechnology

Great West Life Assurance CO

$57.4 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SWTX Spring Works Therapeutics, Inc.	$2.22B	$444,000 0.0% of portfolio	13,831	Q3 2024 Added 152.02%
SNDX Syndax Pharmaceuticals Inc	$740M	$398,000 0.0% of portfolio	20,662	Q2 2024 Added 187.69%
AUPH Aurinia Pharmaceuticals Inc.	$1.28B	$393,000 0.0% of portfolio	53,514	Q4 2023 Added 44.4%
DNLI Denali Therapeutics Inc.	$2.88B	$392,000 0.0% of portfolio	13,434	Q2 2024 Added 38.15%
BCRX Biocryst Pharmaceuticals Inc	$1.41B	$384,000 0.0% of portfolio	50,545	Q3 2024 Added 190.92%
ARVN Arvinas, Inc.	$983M	$359,000 0.0% of portfolio	14,524	Q2 2024 Reduced 18.06%
KURA Kura Oncology, Inc.	$603M	$349,000 0.0% of portfolio	17,836	Q2 2024 Added 184.56%
AXSM Axsome Therapeutics, Inc.	$3.89B	$301,000 0.0% of portfolio	3,351	Q3 2024 Reduced 55.9%
MDGL Madrigal Pharmaceuticals, Inc.	$5.28B	$274,000 0.0% of portfolio	1,289	Q2 2024 Added 31.26%
MDXG Mimedx Group, Inc.	$1.03B	$243,000 0.0% of portfolio	41,033	Q3 2024 Reduced 16.57%
APLS Apellis Pharmaceuticals, Inc.	$3.65B	$232,000 0.0% of portfolio	8,030	Q3 2024 Reduced 57.14%
BEAM Beam Therapeutics Inc.	$2.04B	$225,000 0.0% of portfolio	9,174	Q3 2024 Added 3.9%
CLDX Celldex Therapeutics, Inc.	$1.18B	$215,000 0.0% of portfolio	6,338	Q3 2024 Reduced 53.46%
ARDX Ardelyx, Inc.	$745M	$191,000 0.0% of portfolio	27,680	Q3 2024 Reduced 56.32%
IMVT Immunovant, Inc.	$3.55B	$171,000 0.0% of portfolio	5,987	Q3 2024 Reduced 61.13%
FATE Fate Therapeutics Inc	$163M	$160,000 0.0% of portfolio	45,632	Q3 2024 Added 8.22%
NVAX Novavax Inc	$680M	$149,000 0.0% of portfolio	11,763	Q1 2024 Reduced 0.52%
ARCT Arcturus Therapeutics Holdings Inc.	$411M	$140,000 0.0% of portfolio	6,050	Q3 2024 Added 13.11%
STOK Stoke Therapeutics, Inc.	$460M	$140,000 0.0% of portfolio	11,349	Q3 2024 Added 13.0%
KROS Keros Therapeutics, Inc.	$439M	$139,000 0.0% of portfolio	2,395	Q3 2024 Reduced 69.37%
AKRO Akero Therapeutics, Inc.	$1.36B	$116,000 0.0% of portfolio	4,050	Q3 2023 Added 172.54%
RCKT Rocket Pharmaceuticals, Inc.	$875M	$116,000 0.0% of portfolio	6,276	Q4 2023 Added 25.85%
SAVA Cassava Sciences Inc	$94.2M	$112,000 0.0% of portfolio	3,814	Q3 2024 Reduced 71.55%
NRIX Nurix Therapeutics, Inc.	$935M	$110,000 0.0% of portfolio	4,876	Q2 2024 New
OCUL Ocular Therapeutix, Inc	$654M	$104,000 0.0% of portfolio	11,976	Q2 2024 New
TVTX Travere Therapeutics, Inc.	$1.1B	$97,000 0.0% of portfolio	6,902	Q4 2023 Reduced 82.82%
ORIC Oric Pharmaceuticals, Inc.	$325M	$85,000 0.0% of portfolio	8,324	Q2 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$902M	$77,000 0.0% of portfolio	8,233	Q2 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$134M	$72,000 0.0% of portfolio	46,013	Q3 2024 New
GMAB Genmab A/S	$13.4B	$66,000 0.0% of portfolio	2,710	Q3 2024 Added 44.76%
PLRX Pliant Therapeutics, Inc.	$643M	$62,000 0.0% of portfolio	5,486	Q3 2023 Added 193.21%
RLAY Relay Therapeutics, Inc.	$500M	$61,000 0.0% of portfolio	8,624	Q3 2023 Added 154.02%
EDIT Editas Medicine, Inc.	$90M	$59,000 0.0% of portfolio	17,208	Q3 2024 Reduced 14.29%
ALLO Allogene Therapeutics, Inc.	$269M	$57,000 0.0% of portfolio	20,184	Q3 2024 Reduced 16.22%
PHAT Phathom Pharmaceuticals, Inc.	$292M	$51,000 0.0% of portfolio	2,839	Q3 2023 Added 234.0%
REPL Replimune Group, Inc.	$616M	$48,000 0.0% of portfolio	4,393	Q3 2023 Added 208.5%
YMAB Y M Abs Therapeutics, Inc.	$362M	$40,000 0.0% of portfolio	3,048	Q2 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$39,000 0.0% of portfolio	7,525	Q3 2023 Added 133.33%
ALEC Alector, Inc.	$154M	$36,000 0.0% of portfolio	7,785	Q4 2023 Added 172.68%
SAGE Sage Therapeutics, Inc.	$333M	$35,000 0.0% of portfolio	4,789	Q3 2023 Added 140.77%
SVRA Savara Inc	$368M	$30,000 0.0% of portfolio	7,047	Q1 2024 New
SRRK Scholar Rock Holding Corp	$2.31B	$30,000 0.0% of portfolio	3,777	Q4 2023 Added 230.74%
ALT Altimmune, Inc.	$404M	$27,000 0.0% of portfolio	4,354	Q1 2024 New
PGEN Precigen, Inc.	$158M	$9,000 0.0% of portfolio	9,556	Q3 2024 Added 23.34%
ITOS I Teos Therapeutics, Inc.	$264M	$8,000 0.0% of portfolio	785	Q4 2023 Reduced 96.33%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.